Published in

Springer Nature [academic journals on], British Journal of Cancer, 2(100), p. 228-232, 2008

DOI: 10.1038/sj.bjc.6604801



Export citation

Search in Google Scholar

The spliceosome as target for anticancer treatment

Journal article published in 2008 by R. J. van Alphen, E. A. C. Wiemer ORCID, H. Burger, F. A. L. M. Eskens
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO


The spliceosome is a ribonucleoprotein complex involved in RNA splicing, that is, the removal of non-coding introns from precursor messenger RNA. (Alternative) Splicing events may play an essential role in tumourigenesis. The recent discovery that the spliceosome is a target for novel compounds with anticancer activity opens up new therapeutic avenues.